GLSI
What one share of Greenwich Lifesciences holds
Pharmaceutical Preparations
Greenwich Lifesciences’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Profit | −$1.58 |
|---|---|
| Cash and investments | $0.60 |
| Book value | $0.21 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2019 | — | −$1.52 | — | −$0.13 | — | — |
| 2020 | — | −$0.20 | — | −$0.12 | — | $2.18 |
| 2021 | — | −$0.35 | — | −$0.33 | — | $2.04 |
| 2022 | — | −$0.61 | — | −$0.48 | — | $1.03 |
| 2023 | — | −$0.69 | — | −$0.50 | — | $0.52 |
| 2024 | — | −$1.34 | — | −$0.56 | — | $0.07 |
| 2025 | — | −$1.43 | — | −$0.73 | — | $0.02 |